Does Neurocrine Biosciences Pay Dividends?
Neurocrine Biosciences, Inc. · NBIX · updated
Key facts: Neurocrine Biosciences dividend
Data as of · Source: SmarterDividends data
- As of Nov 22, 2026, Neurocrine Biosciences (NBIX) does not pay a dividend, and SmarterDividends' payment records show no cash dividend from Neurocrine Biosciences.
Cite this page
SmarterDividends, "Does Neurocrine Biosciences Pay Dividends? No," updated Nov 22, 2026, https://smarterdividends.com/does-neurocrine-biosciences-pay-dividends
How Neurocrine Biosciences shareholders earn a return
Without a dividend, Neurocrine Biosciences shareholders earn a return only through changes in the share price, which they collect when they sell. Over the past year, NBIX's share price rose 6.2%, from $141.83 to $150.57.
A company that pays no dividend usually reinvests its earnings in the business, buys back its own shares, or both. Only Neurocrine Biosciences's board of directors can declare a dividend; if it does, the payment will appear on this page the day it shows up in SmarterDividends' payment records.
Dividend-paying companies in Healthcare
Frequently asked questions
Does Neurocrine Biosciences pay dividends?
As of Nov 22, 2026, Neurocrine Biosciences (NBIX) does not pay a dividend, and SmarterDividends' payment records show no cash dividend from Neurocrine Biosciences.
Has Neurocrine Biosciences ever paid a dividend?
Not in SmarterDividends' payment records, which show no cash dividend from Neurocrine Biosciences (NBIX).
Will Neurocrine Biosciences start paying a dividend?
Only Neurocrine Biosciences's board of directors can declare a dividend, and as of Nov 22, 2026 it has not. Any date or amount you see before an announcement is speculation. If Neurocrine Biosciences declares one, it will appear on this page.
How do Neurocrine Biosciences shareholders make money?
Through changes in NBIX's share price, realized when they sell. Without a dividend, there is no regular cash payment to shareholders.
Why doesn't Neurocrine Biosciences pay a dividend?
Neurocrine Biosciences has chosen to keep its cash for the business, share buybacks or other uses rather than pay a dividend; its own reports explain its priorities. Growth companies often skip dividends while they invest heavily.
Related
SmarterDividends data, refreshed daily from public market data. For information only, not investment advice.
